Christoph Merten

Professor

EPFL Institute of Bioengineering

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

LinkedIn

Google Scholar

About

Professor Christoph Merten is a faculty member at the EPFL Institute of Bioengineering, Switzerland. His research focuses on advanced microfluidics techniques, including droplet digital microfluidics, high-throughput antibody discovery, and multiplexed transcriptome profiling. Recent publications highlight innovations in the analysis and sorting of biological samples, as well as efforts to enhance our understanding of the gut microbiome and the mechanisms of SARS-CoV-2 uptake.

Articles (12)

Recovery of phenotypically sorted cells using droplet-digital microfluidics

Year:

2025

Fluorescence-activated droplet sequencing (FAD-seq) directly provides sequences of screening hits in antibody discovery

Year:

2024

Targeted barcoding of variable antibody domains and individual transcriptomes of the human B-cell repertoire using Link-Seq

Year:

2024

Design and construction of a microfluidics workstation for high-throughput multi-wavelength fluorescence and transmittance activated droplet analysis and sorting

Year:

2023

Fluorescence crosstalk reduction by modulated excitation-synchronous acquisition for multispectral analysis in high-throughput droplet microfluidics

Year:

2023

Screening for drivers of SARS-CoV-2 uptake

Year:

2023

Combi-seq for multiplexed transcriptome-based profiling of drug combinations using deterministic barcoding in single-cell droplets

Year:

2022

A microfluidic Braille valve platform for on-demand production, combinatorial screening and sorting of chemically distinct droplets

Year:

2022

Technological and computational advances driving high-throughput oncology

Year:

2022

Enrichment of gut microbiome strains for cultivation-free genome sequencing using droplet microfluidics.

Year:

2022

Targeted Perturb-seq enables genome-scale genetic screens in single cells.

Year:

2020

Microfluidics as an Enabling Technology for Personalized Cancer Therapy

Year:

2020

Collaborators (5)

Michael Ryckelynck

Full Professor of Biochemistry/Group leader

University of Strasbourg

FRANCE

Karl Albert Brokstad

Professor

Western Norway University of Applied Sciences

NORWAY

Jatin Panwar

Swiss Federal Institute of Technology Lausanne (EPFL)

SWITZERLAND

Vida Vafaizadeh

Swiss Federal Institute of Technology Lausanne (EPFL)

SWITZERLAND

Rebecca Jane Cox

Leder av Influensasenteret /Professor

University of Bergen

NORWAY

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI